4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-23-000008
Chief Medical Officer returned 3,708 shares (to the company)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Nuyten Dimitry SA · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-18 | Returned to the company : show line 1 in the form 10b5-1 | −3,708 | $20.40 | $75,643 | 73,591 | D |
Loading xslF345X05/wk-form4_1695242857.xml…